Recent publications
-
Harnessing the COVID-19 Response Towards Hepatitis C Elimination
On February 3, 2021, Treatment Action Group, Médecins du Monde, hepCoalition, and the UNITE network convene a virtual policy dialogue among parliamentarians, global civil society organizations, and community leaders to share how COVID-19 has impacted global hepatitis C virus elimination efforts. The virtual policy dialogue offers an opportunity to reflect on the latest scientific progress and policy innovations from the International AIDS Society COVID-19 Prevention Conference. More
-
African Declaration to Eliminate Hepatitis C and Improve the Health of People Who Use Drugs Cape Town, South Africa, 20 February 2020
We, the community of people working to eliminate hepatitis C in the African region express alarm regarding the increasing impact of drug use, hepatitis C, and other viral co-infections (including HIV and hepatitis B) on the health and well-being of people who use drugs and the limited access to evidence-based services effective for the prevention, diagnosis and treatment of hepatitis C infection and for improving the health of people who use drugs. More
-
Access to Hepatitis C Treatment and Care Among People Who Inject Drugs: Failing People Most Disproportionately Affected ISSUE BRIEF
Accurate, high-quality data on hepatitis C continues to be a struggle for countries that are scaling up treatment access, expanding testing services, and developing national hepatitis plans. There is scarce information about how people who inject drugs are factored into national hepatitis plans and to what extent they are being tested, treated, and linked to harm reduction and other healthcare services. More
-
Who Has Access to Hepatitis C Testing? Liberate Our Diagnostics! ISSUE BRIEF
Accurate, high-quality data on the hepatitis C virus (HCV) continues to be a struggle for countries that are scaling up testing services and linking people to treatment and care, as part of implementing their national hepatitis plans. There is very little in-country information about the availability and pricing of HCV diagnostics and how licensing and pricing barriers may affect how governments determine coverage of testing services. More
-
Activist Guide to Hepatitis C Virus Diagnostics
A new Activist Guide to Hepatitis C Virus Diagnostics is to provide information for you and your community. The Activist Guide aims to provide a deeper focus on diagnosis with updated information about the steps and different technologies involved in diagnosing a person with hepatitis C. It outlines major barriers to accessing testing technologies and services, which are similar to affordable access to the cure. More